ScholarIQanswers from OpenAlex & ORCID
Ross A. Soo
ResearcherPublications, citations & collaboration network
Ross A. Soo is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Ross A. Soo have?
ScholarIQindexed works
Ross A. Soo has 686 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Ross A. Soo have?
ScholarIQcitation count
Ross A. Soo has 20,008 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Ross A. Soo?
ScholarIQh-index
Ross A. Soo has an h-index of 69 in OpenAlex.
What is the i10-index of Ross A. Soo?
ScholarIQi10-index
Ross A. Soo has an i10-index of 222 in OpenAlex.
What is the ORCID of Ross A. Soo?
ScholarIQorcid
The ORCID for Ross A. Soo is on the source record.
What is the OpenAlex record for Ross A. Soo?
ScholarIQopenalex
The OpenAlex for Ross A. Soo is on the source record.
What are the most-cited papers on Ross A. Soo?
ScholarIQmost cited works
Lorlatinib in patients with ALK-positive non-small-cell lung cancer: results from a global phase 2 study
Benjamin Solomon, Benjamin Besse, Todd M. Bauer, Enriqueta Felip, Ross A. Soo, D. Ross Camidge, Rita Chiari, Alessandra Bearz, Chia‐Chi Lin, Shirish M. Gadgeel, Gregory J. Riely, Eng Huat Tan, Takashi Seto, Leonard P. James, Jill S. Clancy, Antonello Abbattista, Jean-François Martini, Joseph Chen, Gerson Peltz, Holger Thurm, Sai‐Hong Ignatius Ou, Alice T. Shaw
De-novo and acquired resistance to immune checkpoint targeting
Nicholas Syn, Michele W.L. Teng, Tony Mok, Ross A. Soo
Isolation and retrieval of circulating tumor cells using centrifugal forces
Han Wei Hou, Majid Ebrahimi Warkiani, Bee Luan Khoo, Zirui Li, Ross A. Soo, Daniel Shao-Weng Tan, Wan‐Teck Lim, Jongyoon Han, Ali Asgar S. Bhagat, Chwee Teck Lim
Glycine Decarboxylase Activity Drives Non-Small Cell Lung Cancer Tumor-Initiating Cells and Tumorigenesis
Wen Cai Zhang, Ng Shyh‐Chang, Yang He, Amit Rai, Shivshankar Umashankar, Siming Ma, Boon-Seng Soh, Li Sun, Bee Choo Tai, Min En Nga, Kishore Bhakoo, Senthil Raja Jayapal, Massimo Nichane, Qiang Yu, Dokeu A. Ahmed, Christie Tan, Wong Poo Sing, John Kit Chung Tam, Thirugananam Agasthian, Monireh Soroush Noghabi, Yin Huei Pang, Haw Siang Ang, Wayne Mitchell, Paul Robson, Philipp Kaldis, Ross A. Soo, Sanjay Swarup, Elaine Hsuen Lim, Bing Lim
Atezolizumab in Combination With Carboplatin and Nab-Paclitaxel in Advanced Squamous NSCLC (IMpower131): Results From a Randomized Phase III Trial
Robert M. Jotte, Federico Cappuzzo, Ihor Vynnychenko, Daniil Stroyakovskiy, Delvys Rodríguez‐Abreu, Maen Hussein, Ross A. Soo, Henry Jacob Conter, Toshiyuki Kozuki, Kuan-Chieh Huang, Vilma Graupner, Shawn W. Sun, Tien Hoang, Helen Jessop, Mark L. McCleland, Marcus Ballinger, Alan Sandler, Mark A. Socinski